Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation

Academic Article

Digital Object Identifier (doi)

Author List

  • Jamy O; Innis-Shelton R; Bal S; Paluri R; Salzman D; Di Stasi A; Costa L; Meredith R; Lamb L; Minagawa K
  • Start Page

  • E396
  • End Page

  • E398
  • Volume

  • 96